Eli Lilly jumps to top 10% in quality rankings, showing strong fundamentals even as Trump pushes for weight loss drug price cut...

This trial is the first and largest study specifically designed to evaluate children and adolescents with severe alopecia areat...

New long-term extension data show approximately 80% of patients achieved or maintained meaningful skin improvement (EASI 75) wi...

Employer-sponsored health insurance costs rise for third year, with average family premiums at $27,000 in 2025. Drug costs and ...

Polio cases drop 99.9%, but funding shortfall could undo progress. Last mile hardest as virus exploits immunity gaps.

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our t...

Trump's vow to slash weight-loss drug prices sent Hims & Hers tumbling. These ETFs are facing new pressure.

Novo Nordisk offers cheap stock with strong moat and long-term growth tailwinds. Trump's drug price cut suggestion caused s...